CCL2 and depressive disorder: With regard to systemic biomarkers, CKD patients affected by depressive disorders had lower plasma levels of MCP-1 and AGEs, as also confirmed by binary logistic regression models, while no differences were observed in the levels of the other evaluated inflammatory markers.